NU SKIN ENTERPRISES, INC.NUSEarnings & Financial Report
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
NUS Q4 2025 Key Financial Metrics
Revenue
$370.3M
Gross Profit
$262.0M
Operating Profit
$23.2M
Net Profit
$14.5M
Gross Margin
70.7%
Operating Margin
6.3%
Net Margin
3.9%
YoY Growth
-16.9%
EPS
$0.27
Financial Flow
NU SKIN ENTERPRISES, INC. Q4 2025 Financial Summary
NU SKIN ENTERPRISES, INC. reported revenue of $370.3M for Q4 2025, with a net profit of $14.5M (3.9% margin). Cost of goods sold was $108.3M, operating expenses totaled $238.7M.
Key Financial Metrics
| Total Revenue | $370.3M |
|---|---|
| Net Profit | $14.5M |
| Gross Margin | 70.7% |
| Operating Margin | 6.3% |
| Report Period | Q4 2025 |
NU SKIN ENTERPRISES, INC. Annual Revenue by Year
NU SKIN ENTERPRISES, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.5B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.5B |
| 2024 | $1.7B |
| 2023 | $2.0B |
| 2022 | $2.2B |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $417.3M | $439.1M | $430.1M | $445.6M | $364.5M | $386.1M | $364.2M | $370.3M |
| YoY Growth | -13.3% | -12.2% | -13.8% | -8.8% | -12.7% | -12.1% | -15.3% | -16.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.74B | $1.59B | $1.58B | $1.47B | $1.39B | $1.44B | $1.42B | $1.41B |
| Liabilities | $931.7M | $899.8M | $876.0M | $817.5M | $637.4M | $655.9M | $624.6M | $600.1M |
| Equity | $810.2M | $686.2M | $706.9M | $651.5M | $754.0M | $787.8M | $799.8M | $805.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.3M | $51.2M | $31.4M | $25.8M | $389000 | $35.8M | $27.5M | $16.6M |
